Donald Muller

Recommended Articles

• Connecting the Dots Between Alzheimer's and Hypertension

  It can be heartbreaking to watch a loved one suffer from dementia. Whether that person is a parent, grandparent, aunt or uncle, or friend, caregivers may feel that the person they once knew is slipping away. What makes the disease even more frustrating is that there isn’t much information on what...

• Adderall: Side Effects, High, Abuse, Withdrawal

  What is Adderall?Adderall is the brand name of a prescription drug that contains a mixture of amphetamine salts, specifically 75% dextroamphetamine and 25% levoamphetamine salts. It belongs to the drug class called central nervous system (CNS) stimulants. It is also classified among...

• What are the Treatment Options for Sinusitis?

  Sinusitis is a very common and painful condition affecting about 37 million people in the country. Unfortunately, this condition is not understood completely and many people end up with the wrong diagnosis and treatment. Appropriate treatment for this condition is really helpful in alleviating the...

• Sleep Apnea's Impact on a Patient's Heart

  Though sleep apnea often causes atrial fibrillation, there is a lack of awareness.Neglecting sleep disorders is easy. They are widely prevalent, and yet poorly diagnosed and an underrated risk factor for many health conditions. Sleep apnea, one of the most common sleep disorders touches 3-7% of the...

• What Are the Complications of Erectile Dysfunction?

  What Are the Complications of Erectile Dysfunction?Erectile dysfunction is a condition that affects an important part of a man’s life. It interferes with his sexual functionality, and this may have adverse effects on both him and his sexual partner(s). Aside from psychological effects, the man...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...